Clinical Trial Update: Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI [Phase 4]

View source ↗

Summary

A Phase 4 trial update comparing peripheral endothelial function in patients who underwent PCI and were treated with ticagrelor versus clopidogrel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Endothelial Dysfunction
• Myocardial Ischemia

Drugs mentioned

• Clopidogrel (Plavix) (clopidogrel)
• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: University Hospital of Limerick | Conditions: Myocardial Ischemia, Coronary Artery Disease | Phase 4 | Status: COMPLETED